Biogen’s Q4 revenue falls 6% to $2.4 billion

American biotechnology firm Biogen Inc. disclosed on Tuesday that it booked $2.4 billion in revenue during the closing quarter for fiscal 2023, which marked a 6% drop compared to the corresponding tri…